...
FMSLARGE

Fresenius Medical Care AG & Co. KGaA

HealthcareMedical - Care Facilities
$23.46
$0.00(+0.21%)
52W$20.95
$30.46
FinancialsValuationvs DVA
Updated Mar 2, 12:00 AM
RSI49
RS Rating35/99
Beta0.40
Volatility30%
F-Score5/9
Mkt Cap$13.6B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Fresenius Medical Care AG & Co. KGaA is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 35), showing significant lag compared to the market leaders. Earnings growth of 9% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.

Relative Strength
35
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.40
vs S&P 500
LOW VOL
52W Position
26%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$23.27
50 SMA > 100 SMA$24.10
100 SMA > 150 SMA$24.48
150 SMA > 200 SMA$25.36

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$23.77-1.29%BELOW
50 SMA$23.27+0.83%ABOVE
100 SMA$24.10-2.67%BELOW
150 SMA$24.48-4.15%BELOW
200 SMA$25.36-7.50%BELOW

Price Performance

1D+0.2%
1W-4.6%
1M+5.7%
3M-1.9%
6M-6.7%
YTD-0.2%
1Y-3.1%
3Y+6.1%
52-Week Trading Range26% from low
$23.46
52W Low$20.95
52W High$30.46

Technical Indicators

RSI (14)NEUTRAL
49.0
305070
VCP ScoreCOOL
5/10
Base depth: 16.0%

Risk Profile

Beta
0.40
52W Vol
30%
ATR
$0.56
Max DD (1Y)
-29%

Volume Analysis

Today
23
50D Avg
517.6K
Vol Ratio
0.00x
Liquidity
MODERATE

Earnings Momentum

Q1'25+333%
$0.26
Q2'25+144%
$0.39
Q3'25+147%
$0.47
Q4'25+850%
$0.57
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+2.52%
5 Years:+1.91%
3 Years:+0.39%
TTM:+1.51%

Compounded Profit Growth

10 Years:+0.68%
5 Years:+5.10%
3 Years:+43.38%
TTM:+259.57%

Stock Price CAGR

10 Years:-5.65%
5 Years:-7.71%
3 Years:+6.07%
1 Year:-3.10%

Return on Equity

10Y Avg:8.3%
5Y Avg:5.1%
3Y Avg:4.4%
Last Year:6.8%

Key Metrics

Market Cap$13.6B
Gross Margin25.6%
Net Margin5.0%
Piotroski F-Score5/9

More FMS Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

FMS vs DVADVATOICCM

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 35 meansFMS outperformed 35% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.40 means 60% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 5/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 5/10 with COOL status.

Frequently Asked Questions

Is FMS in an uptrend right now?

FMS has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is FMS overbought or oversold?

FMS's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.

Is FMS outperforming the market?

FMS has a Relative Strength (RS) Rating of 35 out of 99. FMS is currently lagging the broader market.

Where is FMS in its 52-week range?

FMS is trading at $23.46, which is 77% of its 52-week high ($30.46) and 26% above its 52-week low ($20.95).

How volatile is FMS?

FMS has a Beta of 0.40 and 52-week volatility of 30%. It's less volatile than the S&P 500 - generally more stable.